491 related articles for article (PubMed ID: 26889958)
1. High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.
Kuai R; Li D; Chen YE; Moon JJ; Schwendeman A
ACS Nano; 2016 Mar; 10(3):3015-41. PubMed ID: 26889958
[TBL] [Abstract][Full Text] [Related]
2. Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.
Kornmueller K; Vidakovic I; Prassl R
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382521
[TBL] [Abstract][Full Text] [Related]
3. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
[TBL] [Abstract][Full Text] [Related]
4. A high-density lipoprotein-mediated drug delivery system.
Mo ZC; Ren K; Liu X; Tang ZL; Yi GH
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):132-147. PubMed ID: 27208399
[TBL] [Abstract][Full Text] [Related]
5. HDL mimetic CER-001 targets atherosclerotic plaques in patients.
Zheng KH; van der Valk FM; Smits LP; Sandberg M; Dasseux JL; Baron R; Barbaras R; Keyserling C; Coolen BF; Nederveen AJ; Verberne HJ; Nell TE; Vugts DJ; Duivenvoorden R; Fayad ZA; Mulder WJM; van Dongen GAMS; Stroes ESG
Atherosclerosis; 2016 Aug; 251():381-388. PubMed ID: 27263077
[TBL] [Abstract][Full Text] [Related]
6. Recombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecin.
Zhang X; Chen B
Cancer Lett; 2010 Dec; 298(1):26-33. PubMed ID: 20579804
[TBL] [Abstract][Full Text] [Related]
7. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional changes in high-density lipoprotein induced by chemical modification.
Murakami T; Okamoto H; Kim H
Biomater Sci; 2015 May; 3(5):712-5. PubMed ID: 26222589
[TBL] [Abstract][Full Text] [Related]
9. HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.
Sanchez-Gaytan BL; Fay F; Lobatto ME; Tang J; Ouimet M; Kim Y; van der Staay SE; van Rijs SM; Priem B; Zhang L; Fisher EA; Moore KJ; Langer R; Fayad ZA; Mulder WJ
Bioconjug Chem; 2015 Mar; 26(3):443-51. PubMed ID: 25650634
[TBL] [Abstract][Full Text] [Related]
10. Structural studies of discoidal lipoprotein A-I.
Koppaka V
Cell Mol Life Sci; 2001 Jun; 58(7):885-93. PubMed ID: 11497237
[TBL] [Abstract][Full Text] [Related]
11. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.
Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M
J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747
[TBL] [Abstract][Full Text] [Related]
12. High-Density Lipoprotein Nanobiologics for Precision Medicine.
Mulder WJM; van Leent MMT; Lameijer M; Fisher EA; Fayad ZA; Pérez-Medina C
Acc Chem Res; 2018 Jan; 51(1):127-137. PubMed ID: 29281244
[TBL] [Abstract][Full Text] [Related]
13. Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.
Pownall HJ; Rosales C; Gillard BK; Ferrari M
Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):146-150. PubMed ID: 27826368
[TBL] [Abstract][Full Text] [Related]
14. Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.
McMahon KM; Foit L; Angeloni NL; Giles FJ; Gordon LI; Thaxton CS
Cancer Treat Res; 2015; 166():129-50. PubMed ID: 25895867
[TBL] [Abstract][Full Text] [Related]
15. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
16. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
17. Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.
Rui M; Guo W; Ding Q; Wei X; Xu J; Xu Y
Int J Nanomedicine; 2012; 7():3751-68. PubMed ID: 22888232
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid nanodisc engineering for drug delivery systems.
Murakami T
Biotechnol J; 2012 Jun; 7(6):762-7. PubMed ID: 22581727
[TBL] [Abstract][Full Text] [Related]
19. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.
Tardy C; Goffinet M; Boubekeur N; Ackermann R; Sy G; Bluteau A; Cholez G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R
Atherosclerosis; 2014 Jan; 232(1):110-8. PubMed ID: 24401224
[TBL] [Abstract][Full Text] [Related]
20. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
